Digestive specialists

Crohn's Disease Treatment Options Explained

Save

Crohn's disease treatment includes corticosteroids for flares, immune modulators (azathioprine, methotrexate) for maintenance, and biologic therapies (anti-TNF, vedolizumab, ustekinumab) for moderate to severe disease. Between 30–55% of patients require surgery within 10 years. The goal of modern therapy is mucosal healing, not just symptom control.

Last updated: July 2026History

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

How do doctors decide which treatment to use?

Crohn's disease has no cure, but medications can reduce inflammation, induce remission, and — as with ulcerative colitis — maintain it over time 12. Treatment decisions depend on:

  • Disease location — where in the digestive tract inflammation is most active
  • Severity — mild, moderate, or severe; the presence of fistulas, abscesses, or strictures
  • Prior treatment history — especially whether the patient has had prior exposure to steroids or biologics
  • Complication risk — risk factors for a more complicated disease course include younger age at diagnosis, perianal disease, need for steroids, and deep ulceration on endoscopy 1

The goal of modern Crohn's therapy has shifted from symptom control alone to achieving mucosal healing — healing the intestinal lining itself — which is associated with fewer hospitalizations and surgeries 1.

Corticosteroids: for flares, not long-term use

Corticosteroids (prednisone, methylprednisolone, and the more gut-selective budesonide) are the standard of care for inducing remission in moderate to severe flares. They work quickly — most patients see improvement within days to weeks — but are not suitable for long-term maintenance because of significant side effects with prolonged use (bone loss, diabetes risk, immune suppression, adrenal suppression) 12.

If a patient requires steroids frequently or cannot taper off them, this signals that a steroid-sparing maintenance strategy is needed — typically an immune modulator or biologic.

Immune modulators: azathioprine, 6-MP, and methotrexate

Immune modulators (also called immunosuppressants) work by dampening the overactive immune response that causes intestinal inflammation. The most commonly used are azathioprine, 6-mercaptopurine (6-MP), and methotrexate 1.

These medications are slow to work — full effect may take 3 to 6 months — so they are not used to treat acute flares. They are used as long-term maintenance therapy, either alone or in combination with biologic therapy. Regular blood monitoring is required because of risks of bone marrow suppression and liver toxicity.

Biologic therapies: targeted immune suppression

Biologic therapies are engineered proteins that target specific components of the immune system involved in Crohn's inflammation. Several classes are used 13:

  • Anti-TNF agents (infliximab, adalimumab, certolizumab pegol) — the most widely used biologics for Crohn's, effective for both induction and maintenance of remission
  • Anti-integrin (vedolizumab) — targets gut-specific immune pathways, with a favorable safety profile
  • Anti-IL-12/23 (ustekinumab) — effective for moderate to severe Crohn's, increasingly used as a first- or second-line biologic

A 2021 network meta-analysis in The Lancet Gastroenterology & Hepatology found that combination therapy (a biologic plus an immune modulator) was generally superior to either therapy alone for induction of remission in biologic-naive patients 3. Choice among agents depends on prior treatment history, disease phenotype, safety considerations, and patient preference.

Biologics are given by injection or IV infusion, often indefinitely. Regular monitoring is required.

Small molecule drugs

Newer small molecule oral medications have expanded treatment options for moderate to severe Crohn's:

  • Upadacitinib (Rinvoq) — a JAK inhibitor approved for moderately to severely active Crohn's disease; taken orally once daily
  • Ozanimod — a sphingosine-1-phosphate receptor modulator; approved for Crohn's in some markets

These agents offer the convenience of oral dosing and are generally used in patients who have not responded to or cannot use biologics. As with biologics, monitoring and safety considerations apply 1.

Surgery

Between 30% and 55% of people with Crohn's disease require surgery within 10 years of diagnosis 2. Surgery does not cure Crohn's — disease can recur at or near the surgical site — but it can relieve complications that cannot be managed with medication alone:

  • Bowel obstruction from scarring or stricture
  • Abscess or fistula not responding to antibiotics or biologic therapy
  • Perforation
  • Cancer in the affected segment

Surgeons typically aim to preserve as much bowel as possible. After bowel resection, maintenance medication is recommended to reduce the risk of disease recurrence at the anastomosis site 1.

What about complementary approaches?

Some patients with Crohn's disease use dietary interventions alongside medical therapy. The Crohn's Disease Exclusion Diet (CDED) and exclusive enteral nutrition (EEN) have evidence for inducing remission, particularly in children 2. These are generally used as adjuncts to medical therapy, not replacements.

Stress management, regular physical activity when tolerated, not smoking (smoking worsens Crohn's disease outcomes), and vitamin/mineral supplementation when deficiencies are present all contribute to overall health 12.

Crohn's disease is managed by a gastroenterologist. A multidisciplinary team may include a dietitian, surgeon, and in some cases a psychologist or social worker for the emotional burden of chronic disease. Gale clinicians can help you prepare for a GI specialist visit and coordinate the referral.

Common questions

Corticosteroids (like prednisone) are fast-acting anti-inflammatory medications used to treat acute flares. They are not suitable for long-term maintenance due to significant side effects. Biologics are targeted immune therapies (given by injection or infusion) that are used for maintenance of remission in moderate to severe Crohn's disease.

Spontaneous remission can occur in mild disease, but most people with moderate to severe Crohn's require ongoing medication to maintain remission. Stopping medication without medical guidance typically leads to relapse, and some patients develop complications (strictures, fistulas) that require additional treatment. Decisions about stepping down therapy should always be made with your gastroenterologist.

Most patients see initial response to anti-TNF agents (infliximab, adalimumab) within 8–12 weeks of starting treatment. Ustekinumab and vedolizumab may take a similar or slightly longer time. Full assessment of response typically occurs at the end of the induction phase (8–12 weeks), and maintenance dosing follows if there is a response.

Surgery is often considered when medication has not controlled the disease or when complications arise — abscess, fistula, stricture, or perforation. It is not a failure of treatment. Because Crohn's can recur after surgery, a maintenance medication strategy is typically recommended post-operatively.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Safety considerations for Crohn's treatments

  • —Signs of serious infection while on biologic or immunosuppressant therapy: high fever, chills, wound that won't heal — seek care promptly
  • —Symptoms of bowel obstruction: severe pain, distended abdomen, no gas or stool passage — go to the emergency room
  • —New neurological symptoms, skin rashes, or vision changes after starting a biologic — contact your gastroenterologist

Go to the emergency room or call 911 if you develop severe abdominal pain, signs of bowel obstruction, or serious infection while on immune-suppressing therapy.

This article describes medication classes in general terms and does not constitute a prescription or recommendation for a specific drug. Your gastroenterologist determines which treatment is appropriate for your individual situation. Gale can help you find and prepare for a gastroenterology visit.

Did this answer your question?

References

  1. 1.Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE (2018). ACG Clinical Guideline: Management of Crohn's Disease in Adults. American Journal of Gastroenterology. doi:10.1038/ajg.2018.27 ✓Treatment ladder for Crohn's disease including corticosteroids, immune modulators (azathioprine, 6-MP, methotrexate), biologic therapies, and surgical indications; goals of mucosal healing and steroid-free remission
  2. 2.National Institute of Diabetes and Digestive and Kidney Diseases (2024). Treatment for Crohn's Disease. NIDDK Health Information. link ✓Overview of Crohn's treatment categories: medicines, bowel rest, and surgery. Between 30–55% of people with Crohn's require surgery within 10 years of diagnosis. Medicines include corticosteroids, immunosuppressants, biologics, and small molecule drugs.
  3. 3.Singh S, Fumery M, Sandborn WJ, Murad MH (2021). Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis. The Lancet Gastroenterology & Hepatology. doi:10.1016/S2468-1253(21)00312-5 ✓Network meta-analysis comparing anti-TNF agents, vedolizumab, and ustekinumab for moderate-to-severe Crohn's disease; supports the evidence base for biologic therapy selection in treatment-naive and TNF-exposed patients

3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library